§ 37:1226.1 — Communication to the prescriber

Louisiana § 37:1226.1

• Jurisdiction: Louisiana
• Title 37: Professions and Occupations

Text

§1226.1. Communication to the prescriber
A. No later than five business days following the dispensing of a biological product,
the dispensing pharmacist or his designee shall communicate to the prescriber the specific
product provided to the patient, including the name of the product and the manufacturer.
B. The required communication included in Subsection A of this Section may be
done by any means.
C. No communication shall be required if there is no interchangeable or
therapeutically equivalent biological product approved by the United States Food and Drug
Administration for the product prescribed, or if the prescription is a refill not changed from
the product dispensed on the prior filling of the prescription.
D. Nothing in this Section shall create a cause of action against the prescriber and
the dispensing pharmacist or his designee for a communication as required pursuant to this
Section.
E. No communication shall be required pursuant to this Section if the prescriber
indicates "dispense as written".

Legislative History

Acts 2015, No. 391, §1; Acts 2018, No. 206, §3.